Global 4 Hydroxythiobenzamide market was valued at USD 120 million in 2025 and is projected to reach USD 210 million by 2034, exhibiting a remarkable CAGR of 6.4% during the forecast period. 4 Hydroxythiobenzamide, a sulfur containing amide (CAS 25984 63 8) that appears as a grayish white powder, has transitioned from niche laboratory synthesis to become a strategic intermediate in modern pharmaceutical manufacturing. Its chemical stability, high purity potential, and ability to serve as a building block for anti gout drug Febuxostat as well as emerging anti tumor candidates make it a valuable commodity. Unlike many thio amides, the compound can be purified through crystallization and recrystallization processes that meet stringent GMP requirements, facilitating its integration into large scale API production lines. Get Full Report Here: https://www.24chemicalresearch.com/reports/317846/hydroxythiobenzamide-market